Companies Attending VIVE Event 2025

With offices in Chicago and New York, Flexpoint Ford is a private equity investment firm that has raised over $7.0 billion in capital and specializes in privately negotiated investments in the financial services and healthcare industries. Since the firm’s formation in 2005, we have completed investments in over 40 companies. We are uniquely flexible with respect to investment size, structure and asset class and will invest from $50 million to $500 million in a single transaction.

Developer of a data-driven healthcare staffing platform intended for proactive scheduling and cost optimization. The company's platform analyzes patient demand to predict staffing needs, enabling healthcare systems to build core staff schedules, supplement with temporary workers during peak times, and achieve measurable cost savings while maintaining appropriate staffing levels for patient care.

Operator of a healthcare information network connecting federal agencies and non-federal healthcare organizations to improve patient care and public health nationwide. The network includes several federal agencies, state and regional HIEs, hospitals, and dialysis centers. Vendors can validate their products on the eHealth Exchange platform.

Developer of a referral management platform designed to streamline clinical referrals and care transitions. The company's platform creates an intelligent medical record for retrieving, digitizing, storing, and securing patient records in an easy-to-navigate format with highlighted key terms to reduce record review time, enabling clinical teams to have access to complete medical histories for referred patients.

Provider of healthcare IT consulting and staffing services, specializing in EHR solutions. The company offers a range of products and services, including training, implementation, project management, and optimization. They also provide a Triple Down Support Solution for EHR support and an EHRC Healthcare Institute for employee education. The entity is certified as a women-owned small business.

Provider of institutional capital to the global energy industry. The company offers hybrid debt and structured equity financing and senior and high yield loans to energy projects and companies, upstream and midstream companies and infrastructure projects.

Eight Roads is a venture capital investment arm of Fidelity International Limited and seeks to invest in the consumer service and technology, financial service, healthcare services, media, medical technology, therapeutics and bioscience sectors. The firm was founded in 1969 and based in London, United Kingdom.

82i is a growth services firm working with entrepreneurs who have found product-market fit and are ready to scale. We know firsthand the challenges founders face, so we developed a flexible, on-demand suite of tech-enabled services tailored to the unique needs of growth companies. Powered by our proprietary 82i Operating System, the 82i team hits the ground running to support clients as they secure funding, establish solid operations, develop technology, and build their team. We listen, we learn, and we deliver actionable results from the back office to the boardroom. Bottom line—we make entrepreneurship easier.

Eir Partners is a Miami based investment company and strategic partnership focused exclusively on the dynamic healthcare and technology marketplace. Eir’s flexible model allows for customized collaboration to accelerate disruption, innovation and growth through direct investment and the augmentation of strategic development and acquisition sourcing. The investment model allows for direct platform investments as the sole investor or alongside strategic or other blue chip private equity institutions. Targeted stages of investment include growth equity through control buyouts. For more information on Eir, please visit www.eirpartners.com.

Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.